Loading...

Home
ETF
ANIK

ANIK

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ANIK News

Anika Therapeutics Faces Investor Lawsuit Over Securities Violations

Jan 26 2026Globenewswire

Anika Therapeutics Shares Plunge 27% After Clinical Trial Fails to Meet Primary Endpoints

Jan 24 2026Businesswire

Anika Therapeutics Shares Plunge 27.42% After Clinical Trial Results Fail to Meet Primary Endpoints

Dec 30 2025Businesswire

Anika Therapeutics Faces Investigation After 27.42% Stock Drop Following Clinical Trial Results

Dec 30 2025Newsfilter

Anika Therapeutics Faces Investigation After Hyalofast Trial Misses Key Endpoints

Dec 06 2025Globenewswire

Anika Therapeutics Faces Investigation After 27.42% Stock Drop Due to Trial Results

Dec 06 2025Newsfilter

Reminder for Anika Investors: Bragar Eagel & Squire, P.C. Urges Anika Therapeutics Shareholders to Reach Out About Ongoing Investigation

Oct 09 2025Globenewswire

Biotech Stocks Recover in After-Hours Trading Driven by Positive Sector Trends

Oct 01 2025NASDAQ.COM

ANIKA (ANIK) UPDATE: Bragar Eagel & Squire, P.C. Launches Investigation into Anika Therapeutics, Inc. for the Benefit of Stockholders and Urges Investors to Reach Out to the Firm

Sep 25 2025Globenewswire

Arcturus Therapeutics (ARCT) Rises 8.7%: Could This Signal More Growth Ahead?

Sep 19 2025NASDAQ.COM

Investor Notice: Pomerantz Law Firm Probes Allegations for Anika Therapeutics, Inc. Shareholders – ANIK

Sep 14 2025Globenewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

Sep 08 2025PRnewswire

Investor Notice: Pomerantz Law Firm Probes Allegations for Anika Therapeutics, Inc. Shareholders - ANIK

Sep 06 2025Globenewswire

Anika Announces Inducement Grants in Compliance with Nasdaq Listing Rule 5635(c)(4)

Sep 05 2025Newsfilter

Investor Notice: Pomerantz Law Firm Probes Allegations for Anika Therapeutics, Inc. Shareholders - ANIK

Sep 02 2025Globenewswire

Investor Notice: Pomerantz Law Firm Probes Allegations for Anika Therapeutics, Inc. Shareholders - ANIK

Aug 29 2025Globenewswire